Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2Hui Wang, Xiaoming Yang, Yuntao Zhang et al.|Cell|2020Cited by 802
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 VaccineJo‐Lewis Banga Ndzouboukou, Xionglin Fan, Yandi Zhang et al.|Current Medical Science|2021Cited by 19
SARS‐CoV‐2 evolves to reduce but not abolish neutralizing actionYandi Zhang, Xionglin Fan, Hui Fu et al.|Journal of Medical Virology|2022Cited by 14
Deletion of <i>BCG_2432c</i> from the Bacillus Calmette‐Guérin vaccine enhances autophagy‐mediated immunity against tuberculosisYaqi Wu, Xionglin Fan, Maopeng Tian et al.|Allergy|2021Cited by 10
Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 ProgressionQing Lei, Xionglin Fan, Hongyan Hou et al.|Journal of Immunology Research|2021Cited by 6